Therapy Areas: AIDS & HIV
23 August 2019 - - UK-based specialist HIV company ViiV Healthcare, which is majority owned by UK-based pharmaceutical company GlaxoSmithKline plc (LSE: GSK), with Pfizer Inc. (NYSE: PFE) and Shionogi...
21 August 2019 - United States-based Signant Health has added Anthony Todd Everhart, MD, FACP to the Signant Health Science and Medicine Team as clinical vice president, Internal Medicine, it was repo...
8 August 2019 - Gilead Sciences Canada, a subsidiary of Gilead Sciences Incorporated, has revealed that the Ontario Drug Benefit Program is offering eligible patients access to Biktarvy (bictegravir 5...
26 July 2019 - ViiV Healthcare, a specialist HIV company majority owned by GSK, along with Pfizer Inc and Shionogi Limited as shareholders has revealed data from its phase III TANGO study for treatmen...
25 July 2019 - - US-based biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD) has presented additional results from the DISCOVER trial evaluating an investigational use of Descovy (emtricit...
25 July 2019 - - US-based drugmaker Merck (NYSE: MRK) has presented results from a Phase 1 study evaluating the pharmacokinetics and safety of a prototype subdermal drug-eluting implant for extended a...